Effect of cabergoline on Parkinsonian tremor assessed by long-term actigraphy

European Neurology

Volumn 61, Issue 3, 2009, Pages 149-153

  Binder, Sabine ^a   Deuschl, Günther ^a   Volkmann, Jens ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Accelerometry; Cabergoline; Long term measurement; Rest tremor

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ACTIMETRY; ADD ON THERAPY; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MORNING DOSAGE; MOTOR PERFORMANCE; NAUSEA; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; TREMOR;

AGED; ANTIPARKINSON AGENTS; ERGOLINES; FEMALE; HUMANS; LINEAR MODELS; MALE; MONITORING, AMBULATORY; MOTOR ACTIVITY; PARKINSON DISEASE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREMOR;

EID: 57649130977     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000186505     Document Type: Article

References (11)

1. Pogarell O, Gasser T, van Hilten JJ, Spieker S, Pollentier S, Meier D, Oertel WH: Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. J Neurol Neurosurg Psychiatry 2002;72:713-720.
2. Van Someren EJ, Pticek MD, Speelman JD, Schuurman PR, Esselink R, Swaab DF: New actigraph for long-term tremor recording. Mov Disord 2006;21:1136-1143.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
4. Lance JW, Schwab RS, Peterson EA: Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain 1963;86:95-110.
5. Deuschl G, Bain P, Brin M: Consensus statement of the Movement Disorder Society on Tremor: Ad Hoc Scientific Committee. Mov Disord 1998;13(suppl 3):2-23.
6. Boose A, Spieker S, Jentgens C, Klockgether T, Scholz E, Dichgans J: Assessing tremor severity with long-term tremor recordings. J Neurol Neurosurg Psychiatry 1994;57:397.
7. Salarian A, Russmann H, Wider C, Burkhard PR, Vingerhoets FJ, Aminian K: Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring system. IEEE Trans Biomed Eng 2007;54:313-322.
8. Scholz E, Bacher M, Diener HC, Dichgans J: Twenty-four-hour tremor recordings in the evaluation of the treatment of Parkinson's disease. J Neurol 1988;235:475-484.
9. Thielgen T, Foerster F, Fuchs G, Hornig A, Fahrenberg J: Tremor in Parkinson's disease: 24-hours monitoring with calibrated accelerometry. Electromyogr Clin Neurophysiol 2004;44:137-146.
10. Schrag A, Keens J, Warner J: Ropinirole for the treatment of tremor in early Parkinson's disease. Eur J Neurol 2002;9:253-257.
11. Moller JC, Oertel WH, Koster J, Pezzoli G, Provinciali L: Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial. Mov Disord 2005;20:602-610.